<bill session="110" type="sr" number="307" updated="2013-07-19T22:15:42-04:00">
  <state datetime="2007-09-05">REFERRED</state>
  <status>
    <introduced datetime="2007-09-05"/>
  </status>
  <introduced datetime="2007-09-05"/>
  <titles>
    <title as="introduced" type="official">A resolution supporting efforts to increase childhood cancer awareness, treatment, and research.</title>
  </titles>
  <sponsor id="400194"/>
  <cosponsors>
    <cosponsor id="400619" joined="2007-09-05"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2007-09-05">
      <text>Referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S11119" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="110" type="hr" number="470"/>
    <bill relation="unknown" session="110" type="sr" number="325"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Chemotherapy"/>
    <term name="Child health"/>
    <term name="Clinical trials"/>
    <term name="Curricula"/>
    <term name="Economics and public finance"/>
    <term name="Education"/>
    <term name="Families"/>
    <term name="Federal aid to research"/>
    <term name="Health education"/>
    <term name="Higher education"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Pain"/>
    <term name="Pharmaceutical research"/>
    <term name="Preventive medicine"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>9/5/2007--Introduced.
Calls for Congress to support: (1) efforts to promote awareness about the incidence, symptoms, and options for treatment of, and long-term follow-up for, cancer among children; (2) increased investment in childhood cancer research; (3) incentives to encourage medical trainees and investigators to enter the field of pediatric oncology; (4) incentives to encourage the development of drugs and biologics designed to treat pediatric cancers; (5) policies that encourage participation in clinical trials; (6) medical education curricula designed to improve pain management for cancer patients; and (7) enhanced education, services, and other resources related to late effects from treatment.</summary>
</bill>
